Purdue Pharma L.P.

Pharmaceutical company.

Based in DC

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $260K in lobbying spend across 5 quarterly filings, Purdue Pharma L.P is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.

$260K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$240K
2019$20K

Issues Lobbied

Pharmacy

Lobbying Firms

Penn Avenue Partners

Lobbyists

Timothy Hannegan

Government Agencies Targeted

These are the government entities that Purdue Pharma L.P. disclosed contacting in their lobbying filings.

SENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy

Monitoring legislative and regulatory activities impacting the pharmaceutical industry.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

America's Health Insurance Plans INC (Ahip)
$96.4M total spend
Walgreen Company
$24.4M total spend
Cambia Health Solutions
$14.9M total spend
Association of National Advertisers, INC.
$14.1M total spend
Ascension Health Alliance D/B/A Ascension
$12.8M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.